Efficacy, safety, and tolerability of rimegepant orally disintegrating tablet for the acute treatment of migraine: a randomised, phase 3, double-blind, placebo-controlled trial
Robert Croop, Peter J. Goadsby, David A. Stock, Charles M. Conway, Micaela Forshaw, Elyse G. Stock, Vladimir Coric, Richard B. Lipton
Dive into the research topics of 'Efficacy, safety, and tolerability of rimegepant orally disintegrating tablet for the acute treatment of migraine: a randomised, phase 3, double-blind, placebo-controlled trial'. Together they form a unique fingerprint.